Transmission du virus de l'hépatite C au sein de la population carcérale

Conclusion

Les établissements correctionnels ne sont pas des communautés isolées. La population carcérale adopte une vaste gamme de comportements à risque élevé avant l’incarcération, et une bonne partie de cette population continue à avoir deux comportements de ce type ou plus en prison. Malheureusement, les interventions qui pourraient être efficaces dans la collectivité n’ont pas les effets escomptés en prison en raison du taux élevé de roulement. Les futurs chercheurs devraient tenter de déterminer ce qui pousse la population carcérale à avoir des activités à risque élevé plutôt que de tenter de découvrir des comportements ou des facteurs précis. Cette approche pourrait favoriser l’élaboration d’initiatives de prévention et d’intervention mieux adaptées et plus efficaces visant à réduire la propagation des maladies transmises par le sang dans les établissements correctionnels et dans la collectivité extérieure une fois les détenus mis en liberté.

Références

  1. Service correctionnel du Canada. The national drug strategy for the Correctional Service of Canada. Forum on Corrections Research 2001;13(3):5-6.

  2. Statistique Canada. A graphical overview of crime and the administration of criminal justice in Canada. 1997.

  3. Service correctionnel du Canada. Infectious diseases and control in Canadian federal penitentiaries 2000-2001. 2003.

  4. Service correctionnel du Canada. Backgrounders: The government’s balanced approach. 2003.

  5. Service correctionnel du Canada. Just punishment? HIV infection and AIDS in correctional facilities. Enhancing Community Corrections 1994;6(3):1-5.

  6. Service correctionnel du Canada. Substance abuse program. 2003.

  7. Sibbald B. Methadone maintenance expands inside federal prisons. CMAJ 2002; 167(10):1154-1157.

  8. Zou S, Forrester L, Giulivi A. Hepatitis C update. Can J Public Health 2003;94(2):127-29.

  9. Remis R, Hogg R, KrahnMD, et coll. Estimating the number of blood transfusion recipients infected by hepatitis C virus in Canada, 1960-85 and 1990-92. Rapport à Santé Canada. juin 1998.

  10. Centers for Disease Control and Prevention. Hepatitis C fact sheet. URL: <http://www.cdc.gov/hepatitis>

  11. Zou S, Tepper M, Giulivi A. Hepatitis C in Canada. Can Commun Dis Rep 2001;27S3 <http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/01vol27/27s3/27s3-fra.php>.

  12. Memon MI, Memon MA. Hepatitis C: An epidemiological review. Can Commun Dis Rep 2002;9:84-100.

  13. Zou S, Tepper M, Giulivi A. Current status of hepatitis C in Canada. Can J Public Health 2000;91(suppl 1):S10-S15.

  14. Lino S. Natural history of hepatitis B and C virus infections. Oncology 2002;62(suppl 1):18-23.

  15. Samuel MC, Doherty PM, Bulterys M, et coll. Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiol Infect 2001;127:475-484.

  16. McBride AJ, Ali IM, Cleee W. Hepatitis C and injecting drug use in prisons. BMJ 1994;309(6958):876b-877b.

  17. Pallas J, Farinas-Alvarez C, Prieto D, et coll. Risk factors for monoinfections and coinfections with HIV, hepatitis B and hepatitis C viruses in northern Spanish prisoners. Epidemiol Infect 1999;123:95-102.

  18. Butler T, Spencer J, Cui J et coll. Seroprevalence of markers for hepatitis B, C and G in male and female prisoners – NSW, 1996. Aust N Z J Public Health 1999;23(4):377-85.

  19. Prefontaine RG, Chaudhary RK, Mathias RG. Analysis of risk factors associated with hepatitis B and C infection in correctional institutions in British Columbia. Can J Infect Dis 1994;5(4):153-156.

  20. Long J, Allwright S, Barry J, et coll. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: A national cross sectional survey. BMJ 2001;323(7323):1209-1222.

  21. Malliori M, Sypsa V, Psichogiou M, et coll. A survey of bloodborne viruses and associated risk behaviors in Greek prisons. Addiction 1998;93(2):243-251.

  22. Stark K, Bienzle U, Vonk R, et coll. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol 1997;26(6):1359-1366.

  23. Butler TG, Dolan KA, Ferson MJ, et coll. Hepatitis B and C in New South Wales prisons: Prevalence and risk factors. MJA 1997;166:127-134.

  24. Ford PM. HIV/AIDS in prisons. Can HIV AIDS Policy Law Rev 1999;4(2/3).

  25. Ford PM. Seroprevalence of hepatitis C in a Canadian federal penitentiary for women. Can Commun Dis Rep 1995;21(14):F3-F4.

  26. Pearson M. Voluntary screening for hepatitis C in a Canadian federal penitentiary for men. Can Commun Dis Rep 1995;21(14):F4-F5.

  27. Haber PS, Parsons SJ, Harper SE, et coll. Transmission of hepatitis C within Australian prisons. MJA 1999;171:31-33.

  28. Spaulding A. Hepatitis C in state correctional facilities. Prev Med 1999;28:92-100.

  29. Ford PM, Pearson M, Sankar-Mistry P, et coll. HIV, hepatitis C and risk behavior in a Canadian medium-security federal penitentiary. Q J Med 2000;93:113-119.

  30. Service correctionnel du Canada. The management of hepatitis C in federal penitentiaries. 2001.

  31. Ford PM. Report of Joyceville/Pittsburgh study of HIV and hepatitis C seroprevalence. Correctional Service of Canada 2000.

  32. Ford PM,White C, Kaufmann H, et coll. Voluntary anonymous linked study of the prevalence of HIV infection and hepatitis C among inmates in a Canadian federal penitentiary for women. Can Med Assoc J 1995;153(11):1605-1609.

  33. Reindollar RW. Hepatitis C and the correctional population. Am J Med 1999;107(6B):100S-103S.

  34. Ruiza JD, Molitorb F, Plagenhoefc JA. Trends in hepatitis C and HIV infection among inmates entering prisons in California, 1994 versus 1999. AIDS 2002;16(16):2236-2238.

  35. Long GE, Rickman LS. Infectious complications of tattoos. Clin Infect Dis 1994;18:610-619.

  36. Gore SM, Bird AG, Cameron SO, et coll. Prevalence of hepatitis C in prisons: WASH-C surveillance linked to self-reported risk behaviors. Q J Med 1999;92:25-32.

  37. Waldron T. Sniffing, snorting drugs may raise hepatitis C risk. Medline Plus Health Information. 2003.

  38. Gore SM, 38. Allwright S, Bradley F, Long J, et coll. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: Results of a national cross sectional survey. BMJ 2000;321(7253):78-100.

  39. Christensen PB, Krarup HB, Niesters HGM et coll. Prevalence and incidence of bloodborne viral infections among Danish prisoners. Eur J Epidemiol 2000;16:1043-1049.

  40. Ko YC, Ho MS, Chiang TA, et coll. Tattooing as a risk of hepatitis C virus infection. J Med Virol 1992;38:288-291.

  41. Tsang THF, Horowitz E, Vugia DJ, et coll. Transmission of hepatitis C through tattooing in a United States prison. AJG 2001;96(4):1304-1305.

  42. Post JJ, Dolan KA, Whybin LR, et al. Acute hepatitis C virus infection in an Australian prison inmate: Tattooing as a possible transmission route. MJA 2001;174:183-184.

  43. Crofts N, Thompson S, Wale E, et al. Risk behaviors for blood-borne viruses in a Victorian prison. Aust N Z J Criminol 1996;29:20-28.

  44. Balasekaran R, Bulterys M, Mazen Jamal M, et al. A case-control study of risk factors for sporadic hepatitis C virus infection in the southwestern United States. Am J Gastroenterol 1999;94(5):1341-1346.

  45. Jurgens R. Update on needle and syringe exchange in Swiss prison. Can HIV AIDS Policy Law Newsl 1995;1(4).

  46. Jurgens R. Needle exchanges in prisons: An overview. CanHIV AIDS Policy Law Newsl 1996;2(4).

  47. Correctional Service of Canada. Correction service of Canada releases results of inmate survey at Joyceville institution near Kingston, Ontario. 2003.

  48. Gill O, Noone A, Heptonstall J. Imprisonment, injecting drug use, and bloodborne viruses. BMJ 1995;10(6975):275-276.

    Sources : S. Skoretz, BSc,Université de Guelph; G. Zaniewski, MHSc, N.J. Goedhuis, BSc, Division de l’hémovigilance et des infections acquises en milieu de soins de santé, Centre de prévention et de contrôle des maladies infectieuses, Santé Canada.

Détails de la page

Date de modification :